Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma.

MLA

Lee, Wendy W. L., et al. “Counterproductive Effects of Anti-CD38 and Checkpoint Inhibitor for the Treatment of NK/T Cell Lymphoma.” Frontiers in Immunology, Apr. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1346178.

APA

Lee, W. W. L., Jing Quan Lim, Tang, T. P. L., Daryl Tan, Ser Mei Koh, Kia Joo Puan, Liang Wei Wang, Jackwee Lim, Kim Peng Tan, Wee Joo Chng, Soon Thye Lim, Choon Kiat Ong, & Rotzschke, O. (2024). Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma. Frontiers in Immunology, 1–13. https://doi.org/10.3389/fimmu.2024.1346178

Chicago

Lee, Wendy W. L., Jing Quan Lim, Tiffany P. L. Tang, Daryl Tan, Ser Mei Koh, Kia Joo Puan, Liang Wei Wang, et al. 2024. “Counterproductive Effects of Anti-CD38 and Checkpoint Inhibitor for the Treatment of NK/T Cell Lymphoma.” Frontiers in Immunology, April, 1–13. doi:10.3389/fimmu.2024.1346178.